Introduction: Law No. 12,732/2012 establishes that oncological treatment in the Unified Health System (SUS) must be initiated within 60 days after histopathological diagnosis. The Oncology Monitoring Panel, fed by the SISCAN and SISREG systems, enables monitoring of compliance with the legislation, identification of delays and support for the organization of the oncological care line in the country. Objectives: To analyze urogenital oncological surgeries performed in the state of Pará, based on compliance with Law No. 12,732/2012. Methods: Observational, descriptive, and retrospective study based on the analysis of secondary data extracted from the SUS Hospital Information System (SIH/SUS) and the Oncology Monitoring Panel. Information regarding hospital admissions recorded between 2019 and 2024 was included. The data were organized and tabulated in electronic spreadsheets, separated by sources (national, state, and hospital). A simple descriptive statistical analysis was performed, with calculation of absolute and relative frequencies and percentage variations, in addition to the assessment of annual growth trends. Since the research used exclusively public and freely accessible data, submission to the Research Ethics Committee was not necessary, in accordance with Resolution No. 510/2016 of the National Health Council. Results: In Brazil, approximately 70% of urogenital oncology surgeries met the deadline established by the 60-day law. In the state of Pará, this percentage was 87%, demonstrating better performance. Between 2019 and 2023, the number of urogenital oncology surgeries increased by 18.4% nationwide, while in Pará the growth was 55.3%. In contrast, the total volume of urogenital surgeries in the state showed a moderate variation of 4.5%. The concentration of 82.27% of oncology procedures was observed in two public hospitals in Belém, reinforcing the role of referral centers and suggesting a regionalized organization of the healthcare network. Conclusion: The data indicate advances in the organization of oncological care in the state of Pará, with an increase in surgical capacity for urogenital neoplasms and compliance with the 60-day legislation above the national average. The differentiated tabulation of data sources contributed to highlighting patterns of concentration and growth in care in the state context.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
